EU set for compulsory licensing of IVDs
This article was originally published in Clinica
Executive Summary
National health authorities will be able to grant compulsory licences to companies to produce copies of patented medicinal products and diagnostic kits for export to countries that do not have adequate manufacturing capacity, as of June 29.